Vitamin B1 Deficiency

NeuRemedy® is a natural health product recently approved by Health Canada as “an important factor in supporting healthy nerve function in individuals with polyneuropathy.”

Each NeuRemedy® capsule delivers 150mg of benfotiamine, a lipid-soluble B1 derivative, that the body readily absorbs and retains. When taken as recommended, greater than 50% of people suffering from polyneuropathy experience significant improvement in their symptoms within a month. Some patients report complete relief!

NeuRemedy® – How it Works

NeuRemedy Video
NeuRemedy Video
NeuRemedy Video

A nutritional approach to managing the debilitating symptoms of polyneuropathy, commonly referred to as peripheral neuropathy

Peripheral neuropathy, the most common complication of diabetes, is a debilitating condition of the peripheral nerves which often causes pain, numbness and tingling of the feet and legs. It is estimated that approximately 2.5 million people are currently suffering from peripheral neuropathy in Canada, more than half of which are thought to be undiagnosed. Until recently, the mainstay of treatment for peripheral neuropathy was the use of drugs that sedate and suppress nervous system function and are associated with dangerous side-effects.

Today, there is a new paradigm. Instead of sedating their patients, many doctors have discovered that they can successfully manage – even eliminate - their patients’ symptoms nutritionally with NeuRemedy®, The Neuropathy Vitamin™.

Thiamine deficiency is a well-known cause of peripheral neuropathy

Adequate blood levels of the micronutrient thiamine are essential for the proper functioning of the peripheral nervous system. Studies have shown that people who are thiamine deficient may suffer from bilateral, symmetrical, peripheral neuropathy of the feet and legs.

Reversing thiamine deficiency is often a highly successful method of managing the symptoms of peripheral neuropathy

Many people, including the elderly, diabetics and patients on certain medications are unable to maintain adequate thiamine levels through normal dietary means. These people are prone to develop peripheral neuropathy. NeuRemedy® manages peripheral neuropathy symptoms by delivering a highly bioactive form of thiamine to exactly where it is needed, the nerve cells. NeuRemedy® works to improve the symptoms of peripheral neuropathy not by sedating the patient or suppressing vital nerve function, but by reversing a nutritional deficiency in their nerves.

Many patients experience dramatic relief from their symptoms in as little as three weeks

The active ingredient in NeuRemedy® has been proven in multiple double-blind, placebo studies* to be safe and effective in reducing or eliminating the symptoms associated with peripheral neuropathy. These studies have documented that patients often feel an improvement in symptoms in as little as three weeks. The active ingredient in NeuRemedy®, benfotiamine, has been used successfully to nutritionally manage peripheral neuropathy in Europe and Asia for over fifty years.

NeuRemedy® is a natural health product, certified by Health Canada

Some people experience dramatic relief within a few days of taking NeuRemedy®. Some need to take NeuRemedy® for as long as two months in order to start to experience relief. Patients who stop taking NeuRemedy® often have a return of their original symptoms. Since not everyone suffering from peripheral neuropathy is B1 deficient, NeuRemedy® does not reduce the symptoms of peripheral neuropathy for everyone.

Research Studies

The key ingredient in NeuRemedy, benfotiamine, has been extensively studied in the scientific literature. It has been shown to be highly effective in alleviating numbness, burning, tingling and pain in the feet and legs, a condition known as polyneuropathy. Polyneuropathy is common in diabetics, the elderly and in alcoholics. Take a look at the studies below for further information.

The Pathology of Diabetic Complications

High prevalence of low plasma thiamine concentration in diabetes linked to a marker of vascular disease

The multifaceted therapeutic potential of benfotiamine

Benfotiamine accelerates the healing of ischaemic diabetic limbs in mice through protein kinase B/Akt-mediated potentiation of angiogenesis and inhibition of apoptosis

Effects of thiamine and benfotiamine on intracellular glucose metabolism and relevance in the prevention of diabetic complications

Benfotiamine in the treatment of diabetic polyneuropathy -a three-week randomized, controlled pilot study (BEDIP Study)

Benfotiamine in Diabetic Polyneuropathy (BENDIP): Results of a Randomised, Double Blind, Placebocontrolled Clinical Study